Eastchester, NY, United States of America

Jose L Walewski

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Other. Active years: 2006-2010.

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal3 out of 834,411 
Other
 patents

Years Active: 2006-2010

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Jose L Walewski

Introduction

Jose L Walewski is a notable inventor based in Eastchester, NY (US). He has made significant contributions to the field of hepatitis C research, holding a total of 3 patents. His work focuses on novel polypeptides that have the potential to impact vaccine development and therapeutic strategies.

Latest Patents

Walewski's latest patents include innovative approaches to hepatitis C virus (HCV) polypeptides. One of his patents, titled "Alternate reading frame hepatitis C virus peptides and uses thereof," presents novel HCV polypeptides that are not encoded by the standard HCV open reading frame. These polypeptides are valuable for vaccine compositions, diagnosing HCV infection, and serving as therapeutic targets. Another patent, "Hepatitis C virus peptides and uses thereof," reiterates the importance of these alternate reading frame polypeptides in similar applications.

Career Highlights

Throughout his career, Walewski has demonstrated a commitment to advancing medical research and innovation. His patents reflect a deep understanding of the complexities of hepatitis C and the need for effective solutions in combating this virus.

Collaborations

Walewski has worked alongside talented individuals such as Andrea Branch and Decherd D Stump. Their collaborative efforts have contributed to the development of groundbreaking research in the field of hepatitis C.

Conclusion

Jose L Walewski's contributions to hepatitis C research through his patents highlight his role as an influential inventor. His work continues to pave the way for advancements in vaccine development and therapeutic interventions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…